VERNON HILLS, Ill.--(BUSINESS WIRE)--Elorac, Inc., a rapidly growing specialty pharmaceutical company focused on the treatment of dermatological disorders, will be presenting the results of two important scientific studies at the 23rd World Congress of Dermatology in Vancouver Canada, June 8-13, 2015.
Drs. Scott Phillips, Sr. VP of Scientific Affairs at Elorac, and Madeleine Duvic of the University of Texas MD Anderson Cancer Center will present the promising results of a Phase 2 trial evaluating the safety and efficacy of naloxone lotion for relief of chronic itching in cutaneous T-cell lymphoma.
Help employers find you! Check out all the jobs and post your resume.
